Delivery Order SPE2DR25D2010-SPE2DR26F4ZLN
- Not listed
- The Defense Logistics Agency awarded a $1,149.00 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating the contract was competitively awarded. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.37 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract, awarded on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,258.74 delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract utilizes firm fixed-price pricing with a completion date of December 18, 2025, and was awarded competitively without set-aside restrictions. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 7, 2025, for the supply of Testosterone 1% (25 mg/2.5 g) in 2.5-gram packages. The contract carries a ceiling value of $1,164.38 and employs firm fixed-price pricing with no set-aside designation, indicating the award resulted from open competition. The ultimate completion date is scheduled for May 8, 2025, and the place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, valued at $1,296.00 with a firm fixed price arrangement. This competitively awarded, non-set-aside contract has an ultimate completion date of June 4, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,160.00 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a completion date of December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, serving as the place of performance. This delivery order is...
- The Defense Logistics Agency awarded a $1,941.66 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,172.78. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and is classified as a child order under a larger contract vehicle. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of April 25, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed price delivery order with a ceiling value of $5,004.52 and an ultimate completion date of November 17, 2025. The contract is not set-aside and represents a competitive award to the vendor. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZLNDelivery Order
The Defense Logistics Agency awarded a $1,944 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. Performance is scheduled for completion by December 30, 2025, with fulfillment occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contracts with the Defense Logistics Agency encompasses a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The underlying IDC vehicle enables flexible procurement of pharmaceutical commodities to support Defense Health Agency and other government healthcare systems globally, with the DLA planning future generation contracts to be awarded to multiple regional vendors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/28/25 |